Including contrast MR imaging can help physicians differentiate between perforated and non-perforated appendicitis.
Contrast-enhanced MRI can differentiate between perforated and non-perforated appendicitis among children, and may help guide management decisions in the work-up of pediatric appendicitis, according to a study published in Pediatric Radiology.
Researchers from New York-Presbyterian Hospital/Weill Cornell Medicine, in New York, performed a retrospective review to assess the performance of MRI in differentiating perforated from non-perforated pediatric appendicitis.
The review evaluated the records of 77 patients (mean age 12.2 years) with appendicitis. Twenty-two of the children had perforation. The researchers assessed: appendiceal restricted diffusion, wall defect, appendicolith, periappendiceal free fluid, remote free fluid, restricted diffusion within free fluid, abscess, peritoneal enhancement, ileocecal wall thickening, and ileus.
The results showed that the children who had perforations had a larger mean appendiceal diameter and mean number of MRI findings than the non-perforated group:
Abscess, wall defect, and restricted diffusion within free fluid had the greatest specificity for perforation (1.00, 1.00, and 0.96, respectively) but low sensitivity (0.36, 0.25, and 0.32, respectively). The receiver operator characteristic curve for total number of MRI findings had an area under the curve of 0.92, with an optimal threshold of 3.5. A threshold of any four findings had the best ability to accurately discriminate between perforated and non-perforated cases, with a sensitivity of 82% and specificity of 85%.
The researchers concluded that contrast-enhanced MRI can differentiate perforated from non-perforated appendicitis and the presence of multiple findings increases diagnostic accuracy, with a threshold of any four findings optimally discriminating between perforated and non-perforated cases.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.